Who Paid My Doc
PhIIIb Early Arthritis AVERT2
Research payments
$248,252
Through program year 2021, $248,252 in research payments was reported against PhIIIb Early Arthritis AVERT2, across 52 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $92,619 | 10 |
| 2020 | Research | $76,083 | 20 |
| 2019 | Research | $79,549 | 22 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Ridley Eagan, MN Named on 2 payments
- Antony Hou Upland, CA Named on 2 payments
- Nathaniel Neal Los Alamitos, CA Named on 2 payments
- Christine Codding Oklahoma City, OK Named on 2 payments
- Akgun Ince Creve Coeur, MO Named on 2 payments
- Rakesh Patel Salisbury, NC Named on 2 payments
- Kurt Oelke Glendale, WI Named on 2 payments
- Shirley Pang Fullerton, CA Named on 2 payments
- Alan Kivitz Duncansville, PA Named on 2 payments
- Robert Griffin Wyomissing, PA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.